Egypt, September 2013, Cancer medicines
(n=3 orders)
|
Summary of median MPR across sectors Egypt, September 2013, Cancer medicines
|
|
||||
| Public sector procurement prices (n=3 orders) |
|
|
|
|
|
| Originator brand | 1.18 | |
|
|
|
| Lowest price generic | 0.77 | |
|
|
|
| Comparisons of median MPRs for medicines with prices in both sectors |
|||||
| Public sector procurement prices | Public sector patient prices | % difference public sector patient prices to public sector procurement prices | Number of meds. in both sectors | ||
| Originator brand | |||||
| Lowest price generic | |||||
| Public sector patient prices | Private sector patient prices | % difference private sector patient prices to public sector patient prices | Number of meds. in both sectors | ||
| Originator brand | |||||
| Lowest price generic | |||||